Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GlycoMimetics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GLYC
Nasdaq
8731
https://glycomimetics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GlycoMimetics Inc
GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript
- Mar 28th, 2024 2:12 pm
Q4 2023 GlycoMimetics Inc Earnings Call
- Mar 28th, 2024 6:10 am
GlycoMimetics Inc (GLYC) Posts Quarterly Loss, Aligns with Analyst Projections
- Mar 27th, 2024 2:31 pm
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
- Mar 27th, 2024 11:00 am
Should You Buy GlycoMimetics (GLYC) Ahead of Earnings?
- Mar 21st, 2024 12:50 pm
GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024
- Mar 13th, 2024 11:00 am
Positive Signs As Multiple Insiders Buy GlycoMimetics Stock
- Mar 4th, 2024 2:42 pm
GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference
- Feb 26th, 2024 12:00 pm
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Feb 12th, 2024 12:00 pm
GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687
- Jan 4th, 2024 12:00 pm
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
- Jan 3rd, 2024 12:00 pm
Retail investors in GlycoMimetics, Inc. (NASDAQ:GLYC) are its biggest bettors, and their bets paid off as stock gained 23% last week
- Dec 17th, 2023 1:16 pm
GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia
- Dec 10th, 2023 5:00 pm
Is GlycoMimetics (NASDAQ:GLYC) In A Good Position To Invest In Growth?
- Nov 20th, 2023 10:41 am
GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference
- Nov 9th, 2023 12:00 pm
GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript
- Nov 5th, 2023 1:51 pm
Q3 2023 GlycoMimetics Inc Earnings Call
- Nov 4th, 2023 5:48 am
GlycoMimetics Inc (GLYC) Reports Q3 2023 Financial Results
- Nov 3rd, 2023 2:33 pm
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023
- Nov 3rd, 2023 11:00 am
Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
- Oct 23rd, 2023 12:30 pm
Scroll